The RIGHT pro­tein and the case for cryo-EM with Pro­teros

Last year

PRO­TAC® Pro­tein De­graders: How Arv­inas is Pi­o­neer­ing Po­ten­tial Next-Gen­er­a­tion Treat­ments for Neu­rode­gen­er­a­tive Dis­eases

Last year

A Look In­side the Bou­tique En­roll­ment Agency Spon­sors Are Clam­or­ing to Work With

Last year

How to Ac­cel­er­ate De­vel­op­ment in Nov­el & Ad­vanced On­col­o­gy Ther­a­pies - From the Start­ing Line

Last year

Save Time and Up to 43.5% on Clin­i­cal Tri­al Spend Con­duct­ing Aus­tralian and US Tri­als

Last year

Im­muno-On­col­o­gy 2.0: How Re­gen­eron is Uti­liz­ing its Ex­per­tise in An­ti­bod­ies to Lead the Next Wave of Com­bi­na­to­r­i­al Ap­proach­es in Can­cer Care

2 years ago

No Good Drug Left Be­hind: Sen­si­tiv­i­ty and Speci­fici­ty in Drug De­vel­op­ment Ex­plained

3 years ago

The Path to Pro­duc­tiv­i­ty: Tack­ling the Cri­sis in Drug De­vel­op­ment us­ing Im­proved Pre­clin­i­cal Mod­els

3 years ago

Am­pli­fy the Pa­tient Voice in Clin­i­cal Re­search Tech­nol­o­gy De­vel­op­ment

3 years ago

The new rules of can­cer care: Re­spond­ing to in­creas­ing CMS in­flu­ence on the on­col­o­gy land­scape

3 years ago

Pro­tect­ing the glob­al phar­ma­ceu­ti­cal in­no­va­tion ecosys­tem – what’s at stake?

3 years ago

Achiev­ing Dig­i­tal Trans­for­ma­tion: Un­lock­ing Cost Re­duc­tion, Clin­i­cal Ex­cel­lence & Pre­ci­sion Ther­a­peu­tics Man­u­fac­tur­ing

3 years ago

Gene Edit­ing Tech­nol­o­gy’s $50 Bil­lion Mar­ket Op­por­tu­ni­ty

3 years ago

How In­smed is Pi­o­neer­ing the Next Fron­tier in Rare Dis­ease R&D

3 years ago

Fortress Bio’s Unique Busi­ness Mod­el Ide­al­ly Suit­ed to Thrive in Biotech’s Bear Mar­ket

3 years ago

Why this bou­tique biotech agency is the fu­ture of clin­i­cal re­cruit­ment

3 years ago

The Fu­ture of Vac­cine Re­search: the Evolv­ing Glob­al Land­scape

3 years ago

Has the mo­ment fi­nal­ly ar­rived for val­ue-based health­care?

3 years ago

Forge Bi­o­log­ics’ cGMP Com­pli­ant and Com­mer­cial­ly Vi­able Be­spoke Affin­i­ty Chro­matog­ra­phy Plat­form

3 years ago

Dig­i­tal ther­a­peu­tics: The key to max­i­miz­ing the po­ten­tial of med­i­c­i­nal as­sets

3 years ago

The Tech-En­abled Mod­el Re­shap­ing Health­care

3 years ago

A New Era of Col­lab­o­ra­tion Promis­es to De­liv­er More Val­ue for Pa­tients

3 years ago

Glob­al Trend Da­ta Shows 50% of New Tri­als Have Sites in Asia Pa­cif­ic

3 years ago

Ad­dress­ing the Un­met Needs of Mi­graine Suf­fer­ers Strug­gling with Men­tal Health Chal­lenges

3 years ago
First page Previous page 1234567 Next page Last page
A service from the Financial Times